Insider Trading & Ownership - Tananbaum James B.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Tananbaum James B.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-07-17
Purchase
2023-07-19
2:54 pm
Theseus Pharmaceuticals Inc.THRXForesite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Tananbaum James B.
10% Owner
700,000$2.97$2,079,0001,385,825
(Indirect)
View
2023-05-08
Purchase
2023-05-10
5:49 pm
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
1,780,000$2.8$4,984,00010,192,354
(Indirect)
View
2023-04-05
Purchase
2023-04-06
9:08 pm
PARDES BIOSCIENCES INC.PRDSForesite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
Tananbaum James B.
10% Owner
773,952$1.5$1,160,9288,773,134
(Indirect)
View
2023-04-05
Purchase
2023-04-06
9:08 pm
PARDES BIOSCIENCES INC.PRDSForesite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
773,952$1.5$1,160,92813,583,762
(Indirect)
View
2022-12-29
Purchase
2023-01-03
4:24 pm
Theseus Pharmaceuticals Inc.THRXForesite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Tananbaum James B.
10% Owner
500,000$5$2,500,0001,209,275
(Indirect)
View
2022-12-01
Purchase
2022-12-05
4:24 pm
PARDES BIOSCIENCES INC.PRDSForesite Capital Management V LLC
Tananbaum James B.
Foresite Capital Fund V L.P.
10% Owner
637,420$0.85$541,80712,809,810
(Indirect)
View
2021-12-22
Purchase
2021-12-23
4:52 pm
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
325,000$10$3,250,000325,000
(Indirect)
View
2021-02-19
Purchase
2021-02-23
5:34 pm
FS Development Corp. IIFSIIFS Development Holdings II LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Tananbaum James B.
10% Owner
602,500$10$6,025,000602,500
(Direct)
View
2020-12-03
Purchase
2020-12-04
9:39 pm
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
1,000,000$20$20,000,000125,000
(Indirect)
View
2020-08-14
Purchase
2020-10-19
8:49 pm
FS Development Corp.FSDCFS Development Holdings LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Tananbaum James B.
10% Owner
441,500$10$4,415,000441,500
(Direct)
View
2020-05-13
Sale
2020-05-14
6:01 pm
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
1,450,000$80.13$116,188,5005,830,911
(Indirect)
View
2020-03-17
Sale
2020-03-19
5:15 pm
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
750,000$59$44,250,00013,435,214
(Indirect)
View
2020-02-27
Sale
2020-03-02
5:01 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Fund III L.P.
Foresite Capital Fund IV L.P.
Foresite Capital Management III LLC
Foresite Capital Management IV LLC
Tananbaum James B.
10% Owner
1,000,000$17.07$17,070,0001,229,633
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-03
Disposition
2024-04-05
4:55 pm
N/A
2030-12-02
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
13,779,062$00
(Direct)
View
2023-08-31
Other
2023-08-31
5:22 pm
N/A
N/A
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
FS Development Holdings II LLC
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Fund V L.P.
President and CEO
10% Owner
1,000$02,000
(Indirect)
View
2023-08-31
Disposition
2023-08-31
5:22 pm
N/A
2033-05-31
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
FS Development Holdings II LLC
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Fund V L.P.
President and CEO
10% Owner
16,963,146$02,000
(Direct)
View
2023-06-01
Option Award
2023-06-02
4:14 pm
N/A
2033-05-31
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Director
10% Owner
37,500$037,500
(Direct)
View
2023-02-17
Other
2023-02-22
2:50 pm
N/A
N/A
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
1,100,000$013,038,311
(Indirect)
View
2022-06-13
Option Award
2022-06-15
5:00 pm
N/A
2032-06-13
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
20,250$020,250
(Direct)
View

Ownership
2022-06-13
5:15 pm
N/A
N/A
Theseus Pharmaceuticals Inc.THRXForesite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Tananbaum James B.
10% Owner
0$04,294,621
(Indirect)
View
2022-06-08
Option Award
2022-06-10
4:33 pm
N/A
2032-06-07
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Director
10% Owner
37,500$037,500
(Direct)
View
2021-12-23
Option Award(A)
2022-06-10
4:17 pm
N/A
2031-12-22
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
75,000$075,000
(Direct)
View
2021-12-23
Conversion(A)
2021-12-30
4:30 pm
N/A
N/A
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
4,941,250$04,941,250
(Indirect)
View
2021-12-23
Conversion
2021-12-28
4:30 pm
N/A
N/A
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
4,873,750$08,761,572
(Indirect)
View
2021-12-23
Option Award
2021-12-28
4:30 pm
N/A
2031-12-22
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
7,834,072$08,761,572
(Direct)
View
2021-12-23
Option Award
2021-12-28
4:30 pm
N/A
N/A
PARDES BIOSCIENCES INC.PRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
1,000,000$108,761,572
(Indirect)
View
2021-11-01
Other
2021-11-03
4:17 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
1,963,180$06,628,733
(Indirect)
View
2021-10-04
Option Award
2021-10-06
4:15 pm
N/A
2021-10-03
Gemini Therapeutics Inc.GMTXTananbaum James B.
Director
10% Owner
17,245$04,857,495
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:55 pm
N/A
N/A
Quantum-Si IncQSITananbaum James B.
Director
348,125$0.0011,618,637
(Indirect)
View
2021-06-10
Option Award
2021-06-14
6:55 pm
N/A
N/A
Quantum-Si IncQSITananbaum James B.
Director
5,228,067$01,618,637
(Indirect)
View
2021-06-10
Option Award
2021-06-14
6:55 pm
N/A
N/A
Quantum-Si IncQSITananbaum James B.
Director
1,250,000$101,618,637
(Indirect)
View

Ownership
2021-02-16
9:41 pm
N/A
N/A
FS Development Corp. IIFSIITananbaum James B.
President and CEO
10% Owner
0$05,031,250
(Indirect)
View

Ownership
2021-02-10
6:00 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
0$06,612,181
(Indirect)
View
2021-02-05
Conversion
2021-02-09
4:00 pm
N/A
N/A
Gemini Therapeutics Inc.GMTXTananbaum James B.
Director
2,928,750$03,370,250
(Indirect)
View
2021-02-05
Option Award
2021-02-09
4:00 pm
N/A
N/A
Gemini Therapeutics Inc.GMTXTananbaum James B.
Director
1,500,000$103,370,250
(Indirect)
View
2020-12-07
Conversion
2020-12-09
4:12 pm
N/A
N/A
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
19,675,448$0291,667
(Indirect)
View
2020-12-02
Option Award
2020-12-04
6:32 pm
N/A
2030-12-02
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
40,501$040,501
(Direct)
View

Ownership
2020-12-02
9:06 pm
N/A
N/A
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
0$09,838,311
(Indirect)
View

Ownership(A)
2020-08-19
9:14 pm
N/A
N/A
FS Development Corp.FSDCTananbaum James B.
President & CEO
10% Owner
0$03,018,750
(Indirect)
View
2020-05-12
Conversion
2020-05-14
6:01 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
1,930,198$05,830,911
(Indirect)
View
2020-05-06
Conversion
2020-05-08
08:39 am
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
2,000,000$08,411,109
(Indirect)
View
2020-04-22
Other
2020-04-24
5:00 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
970,842$011,602,954
(Indirect)
View
2020-04-23
Conversion
2020-04-24
5:00 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
1,000,000$011,602,954
(Indirect)
View
2020-04-13
Other
2020-04-15
5:00 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
1,554,692$011,361,219
(Indirect)
View
2020-04-14
Conversion
2020-04-15
5:00 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
1,500,000$011,361,219
(Indirect)
View
2020-03-24
Conversion
2020-03-26
5:53 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
2,170,619$012,500,846
(Indirect)
View
2020-03-18
Other
2020-03-19
5:15 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
1,313,974$013,435,214
(Indirect)
View
2020-03-04
Conversion
2020-03-19
5:15 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Tananbaum James B.
10% Owner
2,130,804$013,435,214
(Indirect)
View
2019-12-20
Exercise
2019-12-23
6:05 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
28,900$305,524,591
(Indirect)
View
2019-12-20
Exercise
2019-12-23
6:05 pm
N/A
2019-12-20
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
289$05,524,591
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next